+ All Categories
Home > Documents > Ppt chapter 54

Ppt chapter 54

Date post: 12-Nov-2014
Category:
Upload: stanbridge
View: 95 times
Download: 2 times
Share this document with a friend
Description:
 
Popular Tags:
39
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins Drugs Acting on the Upper Respiratory Tract Chapter 54
Transcript
Page 1: Ppt chapter 54

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Drugs Acting on the Upper Respiratory Tract

Drugs Acting on the Upper Respiratory Tract

Chapter 54

Page 2: Ppt chapter 54

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Drugs Used to Treat Upper Respiratory Infections

Drugs Used to Treat Upper Respiratory Infections

• Antitussives

– Block the cough reflex

• Decongestants

– Decrease the blood flow to the upper respiratory tract and decrease the overproduction of secretions

• Antihistamines

– Block the release or action of histamine that increases secretions and narrows airways

Page 3: Ppt chapter 54

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Drugs Used to Treat Upper Respiratory Infections (cont.)

Drugs Used to Treat Upper Respiratory Infections (cont.)

• Expectorants

– Increase productive cough to clear airways

• Mucolytics

– Increase or liquefy respiratory secretions to aid clearing of airways

Page 4: Ppt chapter 54

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Sites of Action of Drugs Working on the Upper Respiratory Tract

Sites of Action of Drugs Working on the Upper Respiratory Tract

Page 5: Ppt chapter 54

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

AntitussivesAntitussives

• Actions

– Act directly on the medullary cough center of the brain to depress the cough reflex

• Indications

– Control nonproductive cough

• Pharmacokinetics

– Rapidly absorbed, metabolized in the liver, and excreted in the urine

• Contraindications

– Patients who need to cough to maintain the airway

– Head injury or impaired CNS

Page 6: Ppt chapter 54

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Antitussives (cont.)Antitussives (cont.)

• Caution

– Hypersensitivity or history of narcotic addiction

• Adverse Effects

– Drying effect on the mucous membranes

– CNS adverse effects

– GI upset

Page 7: Ppt chapter 54

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Topical Nasal DecongestantsTopical Nasal Decongestants• Actions

– Sympathomimetic

– Affects sympathetic nervous system to cause vasodilatation

– Causing less inflammation of the nasal membrane

• Indications

– Relieve the discomfort of nasal congestion that accompanies the common cold, sinusitis, and allergic rhinitis

Page 8: Ppt chapter 54

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Topical Nasal Decongestants (cont.)Topical Nasal Decongestants (cont.)

• Pharmacokinetics

– Generally not absorbed systemically

– Any portion of these topical decongestants that is absorbed is metabolized in the liver and excreted in the urine

• Contraindications

– Lesion or erosion in the mucous membranes

• Caution

– Any condition that might be exacerbated by sympathetic activity

Page 9: Ppt chapter 54

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Topical Nasal Decongestants (cont.)Topical Nasal Decongestants (cont.)

• Adverse Effects

– Local stinging and burning

– Rebound congestion

– Sympathomimetic effects

• Drug-to-Drug Interactions

– Cyclopropane or halothane

Page 10: Ppt chapter 54

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

QuestionQuestion

Please answer the following statement as true or false.

Antitussive agents should be used with caution in patients who have a history of addiction.

Page 11: Ppt chapter 54

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

AnswerAnswer

True

Rationale: Caution should also be used in patients who are hypersensitive to or have a history of addiction to

narcotics (codeine, hydrocodone).

Page 12: Ppt chapter 54

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Oral DecongestantsOral Decongestants

• Actions

– Shrink the nasal mucous membrane by stimulating the alpha-adrenergic receptors in the nasal mucous membranes

• Indications

– Promotion of drainage in the sinuses and improving air flow

• Pharmacokinetics

– Well absorbed, widely distributed in the body

– Metabolized in the liver and primarily excreted in urine

Page 13: Ppt chapter 54

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Oral Decongestants (cont.)Oral Decongestants (cont.)

• Contraindications

– Any condition that might be exacerbated by sympathetic activity

• Adverse Effects

– Rebound congestion

– Sympathetic effects

• Drug-to-Drug Interactions

– OTC products that contain pseudoephedrine; taking concurrently can cause serious side effects

Page 14: Ppt chapter 54

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Topical Nasal Steroid DecongestantsTopical Nasal Steroid Decongestants

• Actions

– Exact mechanism of action is not known

• Indications

– Seasonal allergic rhinitis

– Inflammation after the removal of nasal polyps

• Pharmacokinetics

– Generally not absorbed systemically

Page 15: Ppt chapter 54

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Topical Nasal Steroid Decongestants (cont.)

Topical Nasal Steroid Decongestants (cont.)

• Contraindications

– Acute infection

• Caution

– Active infection

– Avoid exposure to airborne infections

• Adverse Effects

– Local burning, irritation, stinging, dryness of the mucosa, and headache

– Suppression of healing can occur in a patient who has had nasal surgery or trauma

Page 16: Ppt chapter 54

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

AntihistaminesAntihistamines• Actions

– Selectively block the effects of histamine at the histamine-1 receptor sites, decreasing the allergic response

– Anticholinergic and antipruritic effects

• Indications

– Seasonal and perennial allergic rhinitis, allergic conjunctivitis, uncomplicated urticaria, and angioedema

• Pharmacokinetics

– Well absorbed, metabolized in the liver, excreted in urine and feces

• Contraindications

– Pregnancy and lactation

Page 17: Ppt chapter 54

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Antihistamines (cont.)Antihistamines (cont.)

• Caution

– Renal or hepatic impairment

– History of arrhythmias

• Adverse Effects

– Drowsiness and sedation

– Anticholinergic effects

• Drug-to-Drug Interactions

– Vary based on the drug

Page 18: Ppt chapter 54

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

ExpectorantsExpectorants

• Actions

– Enhances the output of respiratory tract fluids by reducing the adhesiveness and surface tension of these fluids, allowing easier movement of the less viscous secretions

– Indications

– Symptomatic relief of respiratory conditions characterized by a dry, non-productive cough

• Pharmacokinetics

– Rapidly absorbed, metabolism and excretion has not been reported

Page 19: Ppt chapter 54

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Expectorants (cont.) Expectorants (cont.)

• Adverse Effects

– GI symptoms

– Headache

– Dizziness

– Mild rash

– Prolonged use may result in masking a serious underlying disorder

Page 20: Ppt chapter 54

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

QuestionQuestion

Which of the following is an adverse reaction to topical nasal steroids?

A. Increased nasal drainage

B. Rebound effect

C. Suppression of healing

D. Local ulceration

Page 21: Ppt chapter 54

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

AnswerAnswer

C. Suppression of healing

Rationale: Adverse Effects: local burning, irritation, stinging, dryness of the mucosa, and headache; suppression of healing can occur in a patient who has had nasal surgery or trauma.

Page 22: Ppt chapter 54

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

MucolyticsMucolytics• Actions

– Work to break down mucous in order to aid the high-risk respiratory patient in coughing up thick, tenacious secretions

• Indications

– Patients who have difficulty coughing up secretions

– Patients who develop atelectasis

– Patients undergoing diagnostic bronchoscopy

– Postoperative patients

– Patients with tracheostomies

Page 23: Ppt chapter 54

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Mucolytics (cont.)Mucolytics (cont.)• Pharmacokinetics

– Nebulization or direct instillation into the trachea

• Caution

– Acute bronchospasm, peptic ulcer, and esophageal varicies

• Adverse Effects

– GI upset

– Stomatitis and/or rhinorrhea

– Bronchospasm

– Rash

Page 24: Ppt chapter 54

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Use of Upper Respiratory Tract Agents Across the Lifespan

Use of Upper Respiratory Tract Agents Across the Lifespan

Page 25: Ppt chapter 54

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Prototype AntitussivesPrototype Antitussives

Page 26: Ppt chapter 54

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Prototype Topical Nasal Decongestants Prototype Topical Nasal Decongestants

Page 27: Ppt chapter 54

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Prototype Topical Nasal Steroid Decongestants

Prototype Topical Nasal Steroid Decongestants

Page 28: Ppt chapter 54

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Prototype AntihistaminesPrototype Antihistamines

Page 29: Ppt chapter 54

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Prototype ExpectorantsPrototype Expectorants

Page 30: Ppt chapter 54

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Prototype Mucolytics Prototype Mucolytics

Page 31: Ppt chapter 54

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

QuestionQuestion

What drug enhances the output of respiratory tract fluid by reducing the adhesiveness and surface tension of the fluid, which facilitates the removal of viscous mucus?

A. Guaifenesin

B. Flunisolide

C. Acetylcysteine

D. Dextromethorphan

Page 32: Ppt chapter 54

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

AnswerAnswer

C. Acetylcysteine

Rationale: Actions: Enhances the output of respiratory tract fluid by reducing the adhesiveness and surface tension of the fluid, facilitating the removal of viscous mucus.

Page 33: Ppt chapter 54

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Nursing Considerations for Antitussives Nursing Considerations for Antitussives

• Assessment: History and Physical Exam

• Nursing Diagnosis

• Implementation

• Evaluation

Page 34: Ppt chapter 54

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Nursing Considerations for Topical Nasal Decongestants

Nursing Considerations for Topical Nasal Decongestants

• Assessment: History and Physical Exam

• Nursing Diagnosis

• Implementation

• Evaluation

Page 35: Ppt chapter 54

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Nursing Considerations for Oral Decongestants

Nursing Considerations for Oral Decongestants

• Assessment: History and Physical Exam

• Nursing Diagnosis

• Implementation

• Evaluation

Page 36: Ppt chapter 54

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Nursing Considerations for Topical Nasal Steroid Decongestants

Nursing Considerations for Topical Nasal Steroid Decongestants

• Assessment: History and Physical Exam

• Nursing Diagnosis

• Implementation

• Evaluation

Page 37: Ppt chapter 54

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Nursing Considerations for AntihistaminesNursing Considerations for Antihistamines

• Assessment: History and Physical Exam

• Nursing Diagnosis

• Implementation

• Evaluation

Page 38: Ppt chapter 54

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Nursing Considerations for Expectorants Nursing Considerations for Expectorants

• Assessment: History and Physical Exam

• Nursing Diagnosis

• Implementation

• Evaluation

Page 39: Ppt chapter 54

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Nursing Considerations for MucolyticsNursing Considerations for Mucolytics

• Assessment: History and Physical Exam

• Nursing Diagnosis

• Implementation

• Evaluation


Recommended